We are live on ! Find out more
ENFN

Enfusion, Inc.

Delisted

ENFN was delisted on the 17th of April, 2025.

132 hedge funds and large institutions have $1.08B invested in Enfusion, Inc. in 2025 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 29 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 29

50% more call options, than puts

Call options by funds: $521K | Put options by funds: $348K

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

16% more capital invested

Capital invested by funds: $939M → $1.08B (+$146M)

0% more funds holding

Funds holding: 132132 (0)

0% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 39

Holders
132
Holders Change
Holders Change %
0%
% of All Funds
1.77%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.09%
New
39
Increased
51
Reduced
29
Closed
39
Calls
$521K
Puts
$348K
Net Calls
+$173K
Net Calls Change
-$994K
Name Holding Trade Value Shares
Change
Change in
Stake
FMC
1
FTV Management Company
California
$360M
IC
2
Iconiq Capital
California
$157M
BCM
3
Brown Capital Management
Maryland
$57.3M -$22.2M -2,004,488 -28%
HA
4
HHLR Advisors
Cayman Islands
$55.5M
Vanguard Group
5
Vanguard Group
Pennsylvania
$39.9M +$2.59M +233,883 +7%
BlackRock
6
BlackRock
New York
$38.3M +$2.81M +254,477 +8%
AAM
7
Alpine Associates Management
Florida
$27.2M +$26.9M +2,435,720 New
LECM
8
Lead Edge Capital Management
New York
$26.9M
Janus Henderson Group
9
Janus Henderson Group
United Kingdom
$22.3M +$4.35M +393,651 +24%
New York State Common Retirement Fund
10
New York State Common Retirement Fund
New York
$21.5M
Balyasny Asset Management
11
Balyasny Asset Management
Illinois
$21.5M +$20.8M +1,879,019 +4,003%
TC
12
Trium Capital
United Kingdom
$19.4M +$19.2M +1,739,870 New
UBS Group
13
UBS Group
Switzerland
$18.6M +$17.6M +1,589,237 +2,131%
State Street
14
State Street
Massachusetts
$15.9M +$1.05M +94,838 +7%
Arrowstreet Capital
15
Arrowstreet Capital
Massachusetts
$14.8M +$12.1M +1,098,025 +480%
ACM
16
Ararat Capital Management
Connecticut
$14.1M -$11.9M -1,080,730 -46%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$12.2M +$472K +42,680 +4%
NAM
18
Nexpoint Asset Management
Texas
$9.85M +$9.77M +883,523 New
NCM
19
Nellore Capital Management
California
$9.68M
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$9.02M +$116K +10,466 +1%
GCL
21
Glazer Capital LLC
New York
$8.04M +$7.97M +720,809 New
Millennium Management
22
Millennium Management
New York
$7.82M +$7.63M +689,838 +6,218%
SSA
23
Schonfeld Strategic Advisors
New York
$7.6M +$6.5M +588,226 +632%
Bank of America
24
Bank of America
North Carolina
$7.5M +$3.5M +316,477 +89%
YCM
25
Yakira Capital Management
Connecticut
$6.17M +$6.11M +553,058 New

ENFN Hedge Fund Activity: Q1 2025 in Review

132 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q1 2025, worth a combined $1.08B — up 16% from $939M a quarter earlier.

Fund positioning in ENFN was balanced in Q1 2025: 39 funds opened new positions, 39 closed out, 51 added to existing stakes and 29 trimmed.

The largest buyer was Alpine Associates Management, opening a new position worth an estimated $26.9M. The largest seller was Brown Capital Management, cutting an estimated $22.2M.

  • 132 institutional investors held Enfusion, Inc. (ENFN) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $1.08B of Enfusion, Inc. stock for Q1 2025, up 16% quarter-over-quarter.
  • 39 funds opened new Enfusion, Inc. positions in Q1 2025 and 39 closed out, a net change of 0 holders.
  • The largest Enfusion, Inc. buyer in Q1 2025 was Alpine Associates Management, an estimated $26.9M added.
  • The largest Enfusion, Inc. seller in Q1 2025 was Brown Capital Management, an estimated $22.2M sold.

Based on aggregated 13F filings for Q1 2025.